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Hemisynthesis of deuteriated adenosylhopane
and conversion into bacteriohopanetetrol by
a cell-free system fromMethylobacterium
organophilum†
Wenjun Liu,a Anne Bodlennerb and Michel Rohmer*a
Adenosylhopane is a putative precursor of the widespread bacterial C35 biohopanoids. A concise and
ﬂexible hemisynthesis of adenosylhopane has been developed including as key steps a cross metathesis
between two oleﬁns containing either the hopane moiety or a protected adenosine derivative and a sub-
sequent diimide reduction of the resulting oleﬁn. Reduction by deuteriated diimide allowed deuterium
labelling. This synthetic protocol represents a versatile tool to access to deuteriated composite bacterial
hopanoids required for biosynthetic studies. Deuteriated adenosylhopane was thus converted into
bacteriohopanetetrol by a crude cell-free system from Methylobacterium organophilum in the presence
of NADPH, showing for the ﬁrst time the precursor to product relationship between these two bacterial
metabolites.
Introduction
(22R)-Adenosylhopane 2 (Scheme 1) has been found in fairly
large amounts in a few species of bacteria1a–e and in trace
amounts in many hopanoid producing bacteria.2 Adenosyl-
hopane (and structurally tentatively related hopanoids) is one
of the most common hopanoids in soils,3a–c and the presence
of this biomarker in recent sediments is interpreted in terms
of transport of soils into sediments.3b,4,5
Adenosylhopane 2 is characterized by a unique carbon–
carbon bond between C-30 of the hopane moiety and C-5′ of
adenosine. The commonly occurring configuration of adeno-
sylhopane was determined by circular dichroism and high-
field NMR spectroscopy.1a Trace amounts of (22S)-adenosyl-
hopane as the minor isomer was also reported from Rhodopseu-
domonas acidophila.1b Chemical conversion of adenosylhopane
2 into bacteriohopanetetrol 5 permitted the determination of
the stereochemistry of all asymmetric centres of the side-chain
of bacteriohopanetetrol as 22R, 32R, 33R and 34S.1b Later the
synthesis of the eight side chain diastereomers of bacterio-
hopanetetrol confirmed that the absolute configuration of the C5
unit was identical to that of a D-ribitol linked via its C-5 carbon
atom to the hopane moiety.6 The same configuration was also
found for 35-aminobacteriohopanetriol 6 via chemical corre-
lation with bacteriohopanetetrol.7 This side-chain configur-
ation is consistent with the hypothesis deduced from the
labelling experiments: the additional C5 unit of elongated
hopanoids originates from a D-ribose derivative.8,9 Adenosyl-
hopane was consequently considered as a possible intermediate
in the biosynthesis of C35 hopanoids, leading to bacteriohopa-
netetrol 5 or aminobacteriohopanetriol 6 (Scheme 1).8–10 This
hypothesis has been corroborated by the identification of the
hpnG gene in Methylobacterium extorquens11 and Rhodopseudo-
monas palustris12 and the orf14 gene in Streptomyces coelico-
lor:13 their deletion results in the accumulation of
adenosylhopane 2 and in the absence of the major hopanoids,
bacteriohopanetetrol 5 or aminobacteriohopanetriol 6.
The elucidation of the biosynthesis of the side-chain of C35
hopanoids requires suﬃcient amounts of adenosylhopane for
future enzyme tests. Two distinct methods are available to
produce complex hopanoids: fermentation or chemical syn-
thesis. The amphiphilic character and the poor solubility in
most organic solvents of biohopanoids represent severe limit-
ations for their production by fermentation. Moreover, fermen-
tation is only appropriate for a few major compounds as many
complex hopanoids are produced by bacteria in only trace
amounts. In addition, isolation is until now only performed
on acetylated derivatives requiring a final deprotection to get
the native free metabolites, which is either cumbersome or
simply not available (e.g. for adenosylhopane or bacterio-
hopanetetrol derivatives with carbamoyl groups). Chemical
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synthesis, in contrast, allows an access to a broad range of
naturally occurring hopanoids in suﬃcient amounts. Extensive
work resulted in suitable syntheses of ribosylhopane, bacterio-
hopanetetrol and several other related structures.6,14–17 Some
synthetic strategies are quite successful with excellent stereo-
chemistry control and good overall yields.
No reliable synthesis is, however, available for adenosyl-
hopane. The initial attempts towards the synthesis of adenosyl-
hopane and related hopanoids were mainly based on two routes.
The first strategy, inspired from the hypothetical biogenetic
biosynthetic pathway, relies on a coupling between a C30 triter-
pene derivative and an adenosine derivative. Wittig-type coup-
ling between a triterpene phosphonium salt with an
adenosine-5′-aldehyde substrate led to the formation of adeno-
sylhopane 2 in a very low yield,14 probably due to the steric
hindrance induced by both the adenosine moiety and the
pentacyclic triterpene skeleton in addition to the instability of
the nucleoside-5′-aldehyde in the presence of the strong bases
required for the generation of the non-stabilized phosphor-
ane.18 Even the coupling strategy involving lithium (the smal-
lest cation) activated hopane moiety, which was very eﬃcient
in ribosylhopane 3 synthesis, was disappointing to aﬀord the
bulkier 35-O-benzyl ribosylhopane analogue.17 The second
strategy, which involves a glycosidic coupling between a ribo-
sylhopane derivative and adenine in the presence of a Lewis
acid was also rather unsuccessful, not only because of the poor
solubility of adenine and the ribosylhopane derivative in aceto-
nitrile, which promoted side reactions, but also because of the
formation of both 35α and 35β isomers of adenosylhopane 2.14
Furthermore, the application of this methodology is also
limited considering the number of synthetic steps.
This paper describes an eﬃcient hemisynthesis of adeno-
sylhopane including the possibility of deuterium labelling as
well as the conversion of deuterium labelled adenosylhopane
into bacteriohopanetetrol by a crude cell-free system form
Methylobacterium organophilum, which represents the first
Scheme 1 Biogenetic scheme for the biosynthesis of C35 bacterial hopanoids. Identiﬁed genes in Methylobacterium extorquens, Rhodopseudomo-
nas palustris and Streptomyces coelicolor: (i) hpnH/orf15; (ii) hpnG/orf14; hpnO/orf18.10–13
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direct and indisputable proof for a precursor to product
relationship between adenosylhopane 2 and bacterioho-
panetetrol 5.
Results and discussion
Hemisynthesis of adenosylhopane
The proposed strategy leading to adenosylhopane 2 is a conver-
gent hemisynthesis with an excellent stereochemical control
using commercially available starting materials. Moreover, in
order to meet the need for isotopic labelled hopanoids for bio-
synthetic investigations, this strategy allows also the introduc-
tion of deuterium into the hopanoid structure in the last but
one step. Our synthetic strategy relies on a cross-metathesis as
the key coupling step between a methylene elongated hopane
moiety 10 and a properly protected methylene elongated
5′-deoxy-5′-methyleneadenosine derivative 8 (Scheme 2). This
approach has the advantage of preserving the stereogenic
centres at C-22 on the hopane moiety and at C-4′ of the ribose
derivative and avoids the inconvenient glycosylation between
adenine and ribose,14 which must be regio- and diastereoselec-
tive. Metathesis19 seemed quite attractive because of its high
tolerance towards functional groups and bulky structures,20a,b
its mildness and impressive eﬃciency, and the possibility of
late labelling by deuteriation of the double bond. Cross meta-
thesis is known to be more diﬃcult than dimerization, ring
closing or ring opening metathesis due to the lost advantages
from statistics, entropy and ring tension relief respectively. The
trick is to use alkenes having strong reactivity diﬀerences or an
excess of one counterpart.21a,b It was, however, encouraging to
note that Andrei and Wnuk succeeded in coupling a protected
5′-deoxy-5′-methyleneadenosine with N-Boc-protected six-
carbon amino acids bearing a terminal double bond,22 even if
the methylenetriterpene 10 (Scheme 2) in our synthesis pre-
sents a steric hindrance closer to the terminal double bond
than their cross-metathesis partner. Furthermore, both olefins
8 and 10 have the nice reactivity of terminal monosubstituted
olefins21 to counteract the steric hindrance present one bond
away from the olefin.
Protected 5′-deoxy-5′-methyleneadenosine 8 (Scheme 2) was
obtained by a Wittig methylene elongation of aldehyde 7,
obtained in five steps from commercially available 2′,3′-O-iso-
propylideneadenosine by an adaptation of two published
methods (cf. ESI, Scheme S1†).23a,b In parallel, homohop-30-
ene 10 (Scheme 2), the triterpenic coupling partner, was syn-
thesized in high yield via a Wittig reaction from (22S)-hopan-
29-al 9, synthesized in four steps from hydroxyhopanone
extracted from Dammar resin,15,24 and presenting the C-22
configuration of most bacterial hopanoids.25
Cross metathesis
Cross metathesis reactions between homohop-30-ene 10 and
the 5′-methylene adenosine derivative 8 were tested under
diﬀerent conditions (Scheme 2 and Table 1). Given the high
value of both olefins, and hoping that their reactivity are
diﬀerent enough,21a initial attempts of cross metathesis were
performed with stoichiometric amounts. Reaction with alkene
8 and one equivalent of homohopene 10 in the presence of
Hoveyda–Grubbs catalyst (HII), did not, however, give the cross
coupling product 11 under reflux conditions (Table 1, entry 1).
This lack of reactivity for those two terminal alkenes probably
resulted from the high steric hindrance in the expected metalla-
cyclobutanyl transition state, together with an activation
energy barrier too high to be overcome under classical thermic
conditions. Coupling product 11 was, however, isolated with
an up to 13% yield when the same reaction was performed
under microwave irradiation (Table 1, entry 2). Dimer 15
(Scheme 2) was also isolated in 43% yield, resulting from the
self-metathesis of the nucleoside substrate 8. Unreacted start-
ing materials 8 and 10, were also isolated (Table 1, entry 2).
The product of self-metathesis of homohop-30-ene 10 was not
detected. Ruthenium catalyst Grubbs II (GII) promoted cross
metathesis between 8 and 10 in a lower yield, (Table 1, entry
4), suggesting a higher eﬃciency of HII over GII with those
olefins. Finally, the N,N-dimethylaminosulfonyl group contain-
ing Hoveyda–Grubbs-type complex catalyst Zhan-1B, was found
almost as active as HII for this cross metathesis reaction, and
similar yields were obtained for the coupling product 11 and
dimer 15 (Table 1, entries 2 and 3).
Attempts to obtain olefin 11 from secondary cross meta-
thesis between homohopene 10 and dimer 15 under micro-
wave irradiation at 75 °C did not lead to the formation of the
protected adenosylhopene 11, but allowed the recovery of the
two starting reagents. The inability of dimer 15 to undergo sec-
ondary cross metathesis in addition to its formation from 8
under our conditions but its absence in the cross metathesis
performed by Andrei and Wnuk with a type I olefin as cross
metathesis partner,22 suggest that it belongs to type II olefins
for cross metathesis reactions in Grubbs categorization of alke-
nes.21a Besides, the absence of the product of self-metathesis
of homohop-30-ene 10 suggests that it is a type III olefin in
spite of its terminal alkene.
Reacting two cross metathesis partners of diﬀerent types
using feedstock stoichiometries as low as 1 : 1 normally allows
selective cross metathesis, but in our case the yield remained
low. Given these features, the crucial point to obtain higher
yield for coupling compound 11 was to maintain a low concen-
tration of adenosine derivative 8 compared to that of homo-
hopene 10, minimizing thus the amount of dimerization. A large
excess (10 eq.) of the less reactive homohopene 10 was thus
introduced, and, as expected, the yield of protected adenosyl-
hopene 11 rose significantly from 13% to 59% in the presence
of Zhan-1B catalyst under microwave irradiation (Table 1, entry
5). However, the cross metathesis yield still remained moder-
ate, probably due to the low reactivity of homohopene 10.
Increasing more the stoichiometry ratio was not possible for
solubility reasons.
Under these conditions, the olefinic adenosine substrate 8
was fully consumed, resulting in the formation of 40% of
dimer 15. A prolonged reaction time failed to further increase
the yield in 11, supporting to a greater extent that dimer 15
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was indeed unable to undergo a secondary hetero-metathesis
even with homohop-30-ene 10 in excess. The inability of com-
pound 10 to homodimerize, probably due to a strong steric
hindrance induced by the hopane ring system and the pseudo-
axial position of the side chain, allowed the recycling of the
large excess of olefin 10.
Scheme 2 Hemisynthesis of adenosylhopane 2. (i) Ph3PCH3Br, n-BuLi, DMSO–THF, 50 °C, 98%; (ii) Ph3PCH3Br, n-BuLi, THF, −40 °C, 75%; (iii) meta-
thesis; (iv) NH4OH, H2O, MeOH, CH2Cl2, 4 °C, 91%; (v) PADA, AcOH, Py, 90 °C, 73%; (vi) TFA, CHCl3–CH3OH, 0 °C, 92%; (vii) Ac2O, Py.
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The same reactions were performed in sealed tubes without
microwave irradiation (Table 1, entries 6 and 7). A night long
reaction time was required to reach a slightly lower cross meta-
thesis yield, indicating that the highly beneficial eﬀects of
microwave irradiation did not only arise from the rapid
heating and pressure increase allowed in the microwave oven
(purely thermal/kinetic eﬀect), but also from some specific
thermal microwave eﬀect, such as wall eﬀect and selective
heating of strongly microwave-absorbing heterogeneous cata-
lysts in a less polar reaction medium.
Furthermore, a polar solvent (e.g. dichloromethane) is
required to enhance the heating eﬀect of microwave. Although
perfluorobenzene was reported to be capable of increasing the
activity of cross metathesis catalysts,26 its apolar character
probably led to less eﬃcient heating by microwave, resulting
in a lower yield of 11 in comparison to the one obtained with
the use of dichloromethane (Table 1, entries 2 and 8).
As expected, the cross-metathesis product 11 presented pre-
dominantly the E configuration as shown by the larger vicinal
J30,31 coupling constant of the vinylic protons in the spectrum
of the major E isomer (15.4 Hz) versus the smaller coupling
constant in the spectrum of the minor Z isomer (11.0 Hz).
Based on the integration of the 32-H and 33-H signals of both
protected (E)- and (Z)-adenosylhop-32-ene 11 in the 1H-NMR
spectrum, i.e. (E)-32-H at 4.74 ppm and (Z)-32-H at 5.03 ppm
and (E)-33-H at 4.96 ppm and (Z)-33-H at 4.85 ppm, the relative
amount of E isomer varied from 75% to 80%.
Reduction of the double bond of the protected adenosyl-
hopene 11 turned out to be more challenging than expected.
Catalytic hydrogenation was disappointing even under pressure,
and gave very low yields in the presence of Pd/C (<10%),
Adam’s catalyst (<10%)14,27 or no reaction with Wilkinson’s28
and Crabtree’s29 catalysts. Again, the steric hindrance around
the double bond probably allowed only restricted access or no
access at all for the diﬀerent catalysts to the double bond. This
hindered access to the olefin was circumvented by the use of
the small sized diimide, a short-lived reagent that can be
implicated in the reduction of nonpolar multiple bonds. In a
concerted mechanism, cis-diimide is converted into N2 via a
six-centre transition state corresponding formally to the syn
addition of dihydrogen to the double bond.30a,b Taking into
account that this reaction had to be extended to a deuterium
labelled version, the acid promoted decarboxylation of potass-
ium azodicarboxylate was chosen to generate diimide.31 Fur-
thermore, the acid catalysis may speed up the equilibration of
trans- and cis-diimide, favouring thus the hydrogen transfer
from the cis-isomer to the alkene. Direct treatment of the
N-protected adenosylhopene 11 with potassium azodicarboxylate
and acetic acid, however, led to the partial loss of the 6′-N-
benzoyl group. This protecting group was therefore removed
before diimide reduction using a saturated methanolic
ammonia solution in dichloromethane to aﬀord the N-depro-
tected adenosylhopene 12. Diimide reduction of its double
bond was then achieved by a continuous addition of potass-
ium azodicarboxylate and acetic acid for 36 h and aﬀorded the
expected protected adenosylhopane 13 in 73% yield. The reac-
tion required a large excess of diimide and a long reaction
time, probably because of the steric hindrance around the
double bond, resulting in a low reduction rate in comparison
to the one of the disproportionation of diimide into nitrogen
and hydrazine, the major competing reaction consuming the
reducing agent. In order to minimize this disproportionation,
potassium azodicarboxylate was added to the reaction mixture
in small portions. Acetic acid was added only when the nitro-
gen evolution had ceased, keeping thus a low diimide concen-
tration. Water was also avoided because it had been reported
to be a powerful inhibitor of diimide reductions in aprotic sol-
vents such as pyridine.31 Finally, acid catalysed deprotection of
the acetonide of 13 with a methanolic TFA solution aﬀorded
adenosylhopane 2 in high yield. The reaction was conducted at
0 °C on a rotary evaporator to continuously remove 2,2-
dimethoxypropane and shift the equilibrium. Purification
of free adenosylhopane 2 also proved tricky, due to its amphi-
philic character and its insolubility in polar solvents such as
acetonitrile, methanol and water preventing purification by
reversed phase HPLC. Purification was indeed successfully
achieved by gravity column chromatography on silica gel with
a polar ternary solvent (chloroform–methanol–ammonia).
Deuterium labelling of adenosylhopane
Only minor changes were required to obtain the deuterium
labelled adenosylhopane 2-D (Scheme 3). Olefin 12 was first
treated with CH3O
2H to avoid the presence of extra protons
coming from the exchangeable hydrogens of the amino group
Table 1 Cross-metathesis optimisation for the coupling of 10 and 8
Catalysta Conditions 10/8 ratio Products
1 H II 40 °C, DCM, 24 hb 1/1 No reaction
2 H II MWc, 75 °C, DCM, 3 h 1/1 11 (13%), 15 (43%)
3 Zhan-1B MW, 75 °C, DCM, 3 h 1/1 11 (12%), 15 (45%)
4 G II MW, 75 °C, DCM, 3 h 1/1 11 (6%), 15d
5 Zhan-1B MW, 75 °C, DCM, 3 h 10/1 11 (59%), 15 (40%)
6 H II in sealed tubes, DCM, overnight 10/1 11 (51%), 15 (46%)
7 Zhan-1B in sealed tubes, DCM, overnight 10/1 11 (52%), 15 (43%)
8 H II MW, 75 °C, perfluorobenzene, 3 hb 1/1 11 (6%), 15 (78%)
a 10 mol% of catalyst were used. b Reaction under reflux at ambient pressure. cMW is abbreviation of microwave irradiation. d Yield was not
determined for 15.
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to yield 12-D. Monodeuteriated acetic acid CH3COO
2H (98%
isotope abundance) was adopted as deuterium source to gene-
rate dideuteriodiimide. Reduction of olefin 12-D was much
slower with deuteriodiimide than that with natural abundance
diimide due to a primary deuterium isotope kinetic eﬀect.
This relatively slow reaction resulted in a decreased yield
(60%), but allowed to recover unreacted starting material 12
after 36 h treatment. The 1H-NMR spectrum of the recovered
starting material 12 showed that the E/Z ratio decreased from
5 : 1 before diimide reduction to 1 : 1 after reduction, indicat-
ing a faster hydrogenation rate of the E olefin. This phenom-
enon has been frequently observed in diimide reductions and
is attributed to the more cluttered transition state for a Z
olefin than for an E olefin.30a
The deuterium isotope abundance of the protected adeno-
sylhopane 13-D was determined by mass spectrometry. In spite
of all precautions against water contamination the deuterium
content was not maximal, and the reaction resulted in a
mixture of isotopomers: (30,31-2H2)-13-D (60%), (30-
2H1)- and
(31-2H1)-13-D (31%) and natural abundance 13 (9%). This
incomplete labelling is probably due to the large excess of
CH3COO
2H (60 eq.) having only a 98% isotope abundance and
to the primary deuterium kinetic eﬀect, leading to a mixture of
N2
2H2, N2
2H H and N2H2. Deuterium isotope abundance can
be probably improved by using CH3COO
2H with higher
isotope abundance. The obtained labelling was, however,
largely suﬃcient to perform the incorporation experiments.
Structure of adenosylhopane and of its bisdeuteriated
isotopomer
To confirm the structure, synthetic adenosylhopane 2 was
acetylated (Scheme 2). The spectroscopic data of adenosyl-
hopane di-, tri- and tetraacetate 14a–c were compared with
those of acetylated adenosylhopane isolated from bacteria.1a,b
All the analytical data were consistent with those previously
described. The assignments of the 1H and 13C-NMR signals
were made with the help of 2D NMR (1H–1H COSY, HMBC and
HSQC) and by comparison with those obtained on other
hopanoids.16,32
The structure of protected bisdeuteriated (31,32-2H2)adeno-
sylhopane 13-D was confirmed by comparing its 1H- and
13C-NMR spectra recorded in (2H5)pyridine with those of the
corresponding natural abundance adenosylhopane derivative
18. Four diﬀerent configurations at C-30 and C-31 were
observed after N2
2H2 reduction. Given that diimide reacts
faster with the protected (E)-adenosylhopene 17, which is the
dominant isomer, the major products resulting from syn
addition of deuteriated diimide to the E double bond should
be protected (30R,31R-2H2)- and (30S,31S-
2H2)adenosylhopane,
and the (30R,31S-2H2)- and (30S,31R-
2H2)adenosylhopane dia-
stereomers would be generated by the reduction of protected
(Z)-adenosylhopene by diimide (cf. ESI and Scheme S2† for the
discussion of the stereochemistry of those compounds and the
interpretation of the NMR spectra).
Conversion of adenosylhopane into bacteriohopanetetrol by a
cell free system from Methylobacterium organophilum
Methylobacterium organophilum has been chosen for its sub-
stantial production of hopanoids (up to 13 mg g−1, dry
weight).33 It only synthesizes bacteriohopanetetrol derivatives,
a glycoside and two ethers involving a carbapseudopentose
moiety, free bacteriohopanetetrol being a minor hopanoid.
This makes this bacterium a good candidate for incorporations
Scheme 3 Hemisynthesis of (30,31-2H2)adenosylhopane 2-D. (i) MeOD; (ii) PADA, AcOD, Py, 90 °C and (iii) H2O, 60%, 2 steps; (iv) TFA, CHCl3–
CH3OH, 0 °C, 90%.
Paper Organic & Biomolecular Chemistry
3398 | Org. Biomol. Chem., 2015, 13, 3393–3405 This journal is © The Royal Society of Chemistry 2015
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
6 
Fe
br
ua
ry
 2
01
5.
 D
ow
nl
oa
de
d 
on
 1
0/
3/
20
19
 3
:1
5:
33
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
with a crude cell-free system, since dilution of the deuterium
labelled tetrol synthesized de novo from (2H)adenosylhopane
by the natural abundance endogenous tetrol synthesized
during the culture will be minimal. In addition, in order to
diminish this dilution, unbroken cells and large cell debris
containing most of the hopanoids were removed by centrifu-
gation, and the incubations were only performed with the
resulting supernatant.
According to the hypothetical biogenetic scheme
(Scheme 1), several steps are required for the conversion of
adenosylhopane into bacteriohopanetetrol via ribosylhopane:10
a deadenylation into ribosylhopane, the hemiketal ring-
opening of ribosylhopane and a reduction. To obtain ribosyl-
hopane 3, the postulated precursor,10,13 two pathways have
been proposed for the deadenylation: either a direct hydrolysis
of adenosylhopane to ribosylhopane by a nucleosidase-like
enzyme12 or a phosphorolysis of the nucleotide hemiaminal
with the loss of adenine by a purine nucleoside phosphoryl-
ase-like enzyme, yielding ribosylhopane phosphate.11 In this
case, ribosylhopane 35-phosphate cannot be reduced and has
first to be converted by a phosphatase into ribosylhopane 3
prior reduction. The final step is in all cases the reduction of
the open aldehyde form of ribosylhopane by an NADPH-depen-
dent aldose reductase-type enzyme (Bodlenner and Rohmer,
unpublished results). For those reasons, the incubations were
performed in a phosphate buﬀer or in a phosphate free tri-
ethylamine buﬀer in the presence of NADPH. Adenosylhopane
was introduced as a THF solution. Although the use of this
solvent is not common in enzymatic processes, THF is a good
solvent for this amphiphilic hopanoid and has the advantage
of being water miscible. Fortunately, the presence of 10% THF
in the incubation medium did not aﬀect the enzymes activi-
ties. A lipid extraction followed by acetylation allowed isolation
of bacteriohopanetetrol tetraacetate and analysis of the deuter-
ium labelling by electron impact GC-MS (Fig. 1). Deuterium
incorporation was evaluated from the relative abundances of
the (m + 1)/z and (m + 2)/z versus those of the m/z signals
(Table 2). Evidence that adenosylhopane was eﬃciently con-
verted into BHT in a phosphate buﬀer was shown from intense
2H labelling for all ions containing the side chain [m/z 714
(M+), 699 (M+ − CH3), 654 (M+ − AcOH), 493 (fragment B, ring
C cleavage)], but not for those without the side-chain: [m/z 369
(M+ − side chain), 191 (fragment A, ring C cleavage)] (Fig. 1),34
indicating that the 2H labelling was strictly localized in the C5
side chain as expected (Table 2, entry 2). In order to minimize
the influence of the background noise, only the two most
intense signals of the mass spectrum corresponding to frag-
ments generated by ring C cleavage are shown and considered
for evaluating the conversion of deuteriated adenosylhopane
into bacteriohopanetetrol (Table 2).
Moreover, the ratio of bis- and monodeuteriated isotopo-
mers (d2/d1 = 1.9/1) of adenosylhopane was found unchanged
in the labelled bacteriohopanetetrol (d2/d1 = 1.9/1), indicating
that incubated (2H)adenosylhopane is the only deuterium
source and that there is no significant isotope eﬀect in this
enzymatic conversion, which is logical as no reaction aﬀects
the deuterium labelled carbon atoms in this biosynthetic
pathway.
Fig. 1 Fragmentation of the hopane skeleton by electron impact mass spectrometry.
Table 2 Incorporation of (30,32-2H2)adenosylhopane 2-D into bacterio-
hopanetetrol 5 by cell-free systems from Methylobacterium organo-
philum: 2H isotope abundances of fragments A and Ba
Conditionsb
Fragment A (m/z = 191) Fragment B (m/z = 493)
m + 1/m (%) m + 2/m (%) m + 1/m (%) m + 2/m (%)
1 Referencec 20 ± 4 5 ± 2 28 ± 3 6 ± 1
2 A 19 4 27 47
3 B 21 4 36 19
4 C 24 1d 29 6
5 D 19 2 28 6
a Bacteriohopanetetrol was analysed as tetraacetate by GC/MS. Isotopic
patterns of the fragments were measured according to the signal
intensities observed for m/z (reference signal, 100%), m/z + 1 and m/z +
2. The standard deviation of the signal intensities of both fragments
was calculated from the GC-MS analyses of seven samples of
peracetylated bacteriohopanetetrol 5 isolated from seven diﬀerent cell
batches. A confidence interval of 95% can also be calculated by
doubling the standard deviation value. The intensities if signals of
fragments A and B have a 2% deviation. b All the incorporation
experiments were performed at 30 °C for 24 h. A. Deuteriated
adenosylhopane with cell-free extract in phosphate
buﬀer. B. Deuteriated adenosylhopane with cell-free extract in TEA
buﬀer. C. Decomposed deuteriated adenosylhopane after 24 h in
phosphate buﬀer and then incubated with the cell-free extract in
phosphate buﬀer. D. Deuteriated adenosylhopane with inactivated cell
free system in phosphate buﬀer. c Reference mass spectrum of natural
abundance bacteriohopanetetrol tetraacetate isolated from the
unbroken cells and cell debris pellets recovered after centrifugation
yielding the supernatant utilised for incubations. dHigh signal/noise
ratio.
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In order to confirm that the overall conversion of (2H)ade-
nosylhopane 2-D into bacteriohopanetetrol 5 is purely enzy-
matic, (2H)adenosylhopane 2-D was incubated with a cell-free
system inactivated by boiling. No deuterium labelling was
found in the bacteriohopanetetrol isolated from this assay
(Table 2, entry 5).
A non-enzymatic conversion of (2H)adenosylhopane 2-D
into ribosylhopane 3 (or into ribosylhopane phosphate) was
also excluded since a 3 days preincubation of (2H)adenosyl-
hopane in a phosphate buﬀer with 10% THF at 30 °C did not
lead to any detectable deuterium incorporation, even though a
partial degradation of adenosylhopane was observed on TLC.
Incubation of such a degraded sample resulted in no for-
mation of 2H labelled bacteriohopanetetrol, indicating that
even the decomposition products of (2H)adenosylhopane
cannot be converted into bacteriohopanetetrol (Table 2,
entry 4).
The present conversion of deuterium labelled adenosyl-
hopane 2 into bacteriohopanetetrol 5 by a crude cell-free system
of Methylobacterium organophilum in the presence of NADPH,
indicates that the nucleoside side chain of adenosylhopane 2
is the precursor of the D-ribitol side chain of bacterio-
hopanetetrol 5. This biotransformation requires at least two
reactions, depending on the nature of the nucleophile (phos-
phate or water) responsible of the cleavage of the glycosidic
bond with adenine loss. Hoping to solve that question, the
(2H)adenosylhopane incubations with a cell-free system of M.
organophilum were performed using two diﬀerent buﬀers.
Although, the conversion was significantly higher in the phos-
phate buﬀer than in the phosphate free triethylamine buﬀer
(Table 2, entries 2 and 3), there is no clear cut conclusion in
favour of one of the two proposed deadenylation mechanism.
A suﬃcient phosphate concentration originating from the cells
might indeed be still present in the triethylamine buﬀer to
achieve the phosphorolysis, and a slight inhibitory eﬀect on
the putative aldose reductase of triethylamine/triethylammo-
nium cannot be excluded to explain the lower yields. In fact,
ribosylhopane is eﬀectively an intermediate in biohopanoid
biosynthesis. Deletion of the orf18 gene in a S. coelicolor
strain (corresponding to the hpnO gene in M. extorquens and
R. palustris)11,12 allowed to identify for the first time in
the Δorf18 mutant ribosylhopane 3 (Scheme 1), postulated
twenty years ago as an intermediate in the biosynthesis of
C35 hopanoids.
10,15 It is accumulated in the absence of
the putative transaminase encoded by the hpnO/orf18 gene
catalysing the reductive transamination of the free aldehyde
4 into aminobacteriohopanetriol 6.13 Decisive proofs will be
obtained later with tests performed with the isolated and
purified enzymes.
In the final step, a reduction converts the open free alde-
hyde 4 of ribosylhopane 3 into bacteriohopanetetrol 5, which
has been found to be NADPH-dependent (Bodlenner and
Rohmer, unpublished results). The reaction resembles the
reduction catalysed by an aldose reductase, but the gene
encoding this enzyme is yet unknown in hopanoid producing
bacteria.
Conclusion
A highly eﬃcient synthesis of adenosylhopane and its deuter-
ium labelled homologue has been achieved from the coupling
of homohop-30-ene and a 5′-methylene adenosine derivative
via a cross-metathesis. This approach was found to be the only
one able of linking the two highly hindered hopane and
adenine counterparts to date, aﬀording thus a total control of
all the stereogenic centres of this large molecule. Moreover the
metathesis step allows further labelling through the reduction
of the introduced double bond by diimide. The deuterium
labelled adenosylhopane was thus obtained and incubated
with a supernatant of a crude cell-free system of Methylobacter-
ium organophilum yielding deuterium labelled bacteriohopane-
tetrol as shown by EI-MS of its tetraacetate. This allowed for
the first time to demonstrate the substrate to product relation-
ship between adenosylhopane and bacteriohopanetetrol. This
work opens also the way for the eﬃcient synthesis of other bio-
hopanoids and for further enzymatic studies on isolated
enzymes required for the full elucidation of hopanoid
biosynthesis.
Experimental
Reagents and solvents
Reagents were purchased from Sigma-Aldrich, Acros, Alfa
Aesar or Carl Roth. Their purity was more than 98% in all
cases. Dowex 50 (H+) resin was purchased from Aldrich and
was activated right before use with a 10% HCl solution in
water.
All solvents were distilled before use. Dry solvents used in
moisture sensitive reactions were obtained as follows: THF was
freshly distilled from sodium benzophenone ketyl before use.
CH2Cl2 was distilled over P2O5. Pyridine was distilled over KOH
and then stored over molecular sieves (4 Å). DMSO was pur-
chased from Aldrich (sure sealed) and used directly.
Purification techniques
The progress of reactions was monitored by analytical thin
layer chromatography using aluminum-coated Merck 60 F254
silica plates. UV visible spots were directly visualized under UV
light at λ = 254 nm. Hopanoids were revealed on TLC plate by
UV light (λ = 366 nm) after spraying with a 0.1% berberine
hydrochloride solution in EtOH.
Most products were purified by flash column chromato-
graphy using Merck 60 (230–400 mesh) silica gel and appropri-
ate eluents.35 Adenosylhopane 2 and 2-D were purified by
gravity column chromatography using Merck 60 (63–200 µm)
silica gel. Compounds in amounts below 10 mg were purified
via preparative thin layer chromatography using Merck 60 F254
silica gel plates (0.25 mm layer thickness).
Spectroscopic analysis
1H-NMR and 13C-NMR were performed on BRUKER Avance
600 spectrometer (600 MHz for 1H, 150 MHz for 13C), Bruker
Paper Organic & Biomolecular Chemistry
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Biospin 500 spectrometer (500 MHz for 1H, 125 MHz for 13C)
and BRUKER Avance 300 spectrometer (300 MHz for 1H,
75 MHz for 13C). Most of the measurements were carried out
using C2HCl3 as solvent and with CHCl3 (δ = 7.26 ppm) as
internal standard for 1H-NMR and C2H Cl3 (δ = 77.0 ppm) for
13C-NMR. NMR spectra of adenosylhopane 2 and 2-D were
recorded in (2H5)pyridine as solvent and with (
2H4)pyridine
(δ = 8.73, 7.58 and 7.21 ppm) as internal standard for 1H-NMR
and (2H5)pyridine (δ = 149.9, 135.5 and 123.5 ppm) for
13C-NMR. The following abbreviations represent the multi-
plicity of the NMR signals: s, singlet; d, doublet; t, triplet; q,
quadruplet; m, multiplet; dd, doublet of doublet; ddd, doublet
of doublet of doublet; dddd, doublet of doublet of doublet of
doublet; arom., aromatic protons or carbon atoms; br, broad.
1H- and 13C-NMR assignments of hopanoids were based on
earlier assignments14,17,32 and were supported by additional
experiments including DEPT, HSQC and HMBC techniques.
13C shift values of the carbon atoms in the hopanoid skeleton
did not depend significantly on the nature of the side-chain
and remained virtually unchanged after introduction of new
carbon atoms or functional groups in the C5 side-chain.
GC-MS spectra were acquired on a Thermo TSQ Quantum
mass spectrometer connected to a Thermo Trace GC ultra gas
chromatograph (PTV injector, HP-5 MS column, 30 m,
0.25 mm internal diameter, 0.25 μm film thickness). Helium
(constant flow 1 mL min−1) was used as carrier gas. The temp-
erature program for GC analysis was: 3 min at 55 °C, from
55 °C to 320 °C at 10 °C min−1 and 50 min at 320 °C.
Mass spectra were obtained by direct inlet on a Thermo
TSQ Quantum mass spectrometer at 70 eV in the electron
impact positive ionization mode (EIMS) over a mass range of
50–800 Da (cycle time 0.5 s). The source temperature was set at
230 °C.
ESI-HRMS mass spectra were carried out on a Bruker Micro-
TOF spectrometer.
Melting points were measured with a BIBBY SMP3 appar-
atus and are corrected with benzophenone (m.p. 48 ± 1.5 °C).
Optical rotations were measured on a Perkin Elmer 341 polari-
meter at 20 ± 2 °C and 589 nm using 10 cm length and 1 mL
volume cell.
(22S)-Homohop-30-ene (10)
A suspension of NaH (126 mg, 5 mmol) in DMSO (2.5 mL) was
stirred at 75 °C for 50 min. The light green suspension was
cooled down to room temperature, added into a solution of
PPh3CH3Br (1.9 g, 5.4 mmol) in DMSO (27 mL) and stirred at
room temperature for 20 min to aﬀord a light green-grey sus-
pension. The resulting mixture was then added into a solution
of aldehyde 9 (297 mg, 0.70 mmol) in THF (20 mL) and stirred
overnight at 50 °C. The reaction was quenched with water, and
extracted three times with pentane. The combined organic
phases were dried over anhydrous Na2SO4, filtered through
cotton, and evaporated to dryness in vacuo to give an almost
pure crystalline product, which was further purified by flash
chromatography (petroleum ether) to yield the terminal olefin
10 (290 mg, 98%). Rf 0.67 (petroleum ether–EtOAc, 20 : 1).
M.p. = 203–205 °C.
1H-NMR (300 MHz, C2HCl3): δ/ppm = 5.53 (1H, ddd, J30,31a =
17.8 Hz, J30,31b = 9.5 Hz, J22,30 = 9.1 Hz, 30-H), 4.85 (1H, ddd,
J30,31a = 17.8 Hz, Jgem = 2.0 Hz, J22–31a = 0.5 Hz, 31-Ha), 4.85 (1H,
dd, J30,31b = 9.5 Hz, Jgem = 2.0 Hz, 31-Hb), 2.21 (1H, ddq, J21,22 =
9.7 Hz, J22,30 = 9.1 Hz, J22,29 = 6.5 Hz, 22-H), 1.8 (1H, tdd, J21,22 =
9.7 Hz, J20,21 = J17,21 = 4.8 Hz, 21-H), 1.01 (3H, d, J22,29 = 6.5 H,
22R-Me), 0.960 (6H, s, 8β-Me and 14α-Me), 0.851 (3H, s, 4α-Me),
0.818 (3H, s, 10β-Me), 0.796 (3H, s, 4β-Me), 0.710 (3H, s,
18α-Me).
13C-NMR (75 MHz, C2HCl3): δ/ppm = 145.3, 112.0, 56.1,
54.1, 50.4, 49.2, 45.0, 44.4, 42.2, 42.1, 41.9, 41.8, 41.7, 40.3,
37.4, 33.5, 33.4, 33.3, 33.2, 27.6, 24.0, 22.3, 22.0, 21.6, 20.9,
18.7, 16.6, 15.9.
EI-MS (direct inlet, positive mode 70 eV): m/z = 424 (M+,
19%), 409 (M+–CH3, 5%), 369 (M
+–side chain, 20%), 203 (ring
C cleavage, 100%), 191 (ring C cleavage, 88%).
N-Benzoyl-33,34-O-isopropylidene-adenosylhopene (11) and
homodimer (15)
Procedure A. Olefins 10 (156 mg, 0.37 mmol) and 8 (15 mg,
0.037 mmol) and Ru-catalyst (10 mol%) were dissolved in dry
DCM (3.6 mL) at ambient temperature under an atmosphere
of argon and the resulting solution was heated overnight at
75 °C (oil bath) in a pressure tube (Ace glass). Volatiles were
evaporated and the residue was purified by flash chromato-
graphy (DCM to DCM–MeOH 100 : 3) to aﬀord compound 11
(15 mg, 52%, E/Z ∼4 : 1) as a mixture of two isomers and dimer
15 (6 mg, 43%) as a by-product.
Procedure B. Olefins 10 (210 mg, 0.49 mmol) and 8 (20 mg,
0.049 mmol) and Ru-catalyst (10 mol%) were dissolved in dry
CH2Cl2 (5 mL) in a sealed tube equipped with a Teflon-coated
stirrer bar and heated under microwave irradiation at 75 °C for
3 h. The mixture was then evaporated to dryness in vacuo and
purified by flash chromatography (CH2Cl2 to CH2Cl2–MeOH,
100 : 3) to aﬀord compound 11 (23 mg, 59%, E/Z ∼4 : 1) and
dimer 15 (7.5 mg, 40%). Compound 11 was isolated as a col-
ourless solid mixture of the E/Z isomers that were not separ-
ated. Rf 0.47 (CH2Cl2–MeOH, 100 : 3).
1H-NMR (300 MHz, C2HCl3) of (E)-11 and (Z)-11 (subscripts
“E” and “Z” characterize respectively the 1H-NMR signals of
(E)-11 and (Z)-11, which are respectively present in a 4 : 1
ratio): δ/ppm = 9.29 (1H, br. s, –NHCvO), 8.82 (1H, s, 2′-H),
8.12 (0.2H, s, 8′-HZ), 8.10 (0.8H, s, 8′-HE), 8.04–8.01 (2H, m,
Ar–H), 7.61–7.47 (3H, m, Ar–H), 6.14 (1H, d, J34,35 = 1.9 Hz, 35-HZ
and 35-HE), 5.55 (0.8H, dd, J33,34 = 6.2 Hz, J34,35 = 1.9 Hz,
34-HE), 5.51 (0.2H, dd, J33,34 = 6.1 Hz, J34,35 = 1.8 Hz, 34-HZ),
5.46 (0.8H, dd, J30,31 = 15.4 Hz, J22,30 = 8.9 Hz, 30-HE), 5.37
(0.8H, dd, J30,31 = 15.4 Hz, J31,32 = 7.4 Hz, 31-HE), 5.28 (0.4H,
dd, J30,31 = 11.0 Hz, J31,32 = 8.7 Hz, 30-HZ and 31-HZ), 5.03
(0.2H, dd, J31,32 = 8.7 Hz, J32,33 = 3.0 Hz, 32-HZ), 4.96 (0.8H, dd,
J33,34 = 6.2 Hz, J32,33 = 3.0 Hz, 33-HE), 4.85 (0.2H, dd, J33,34 =
6.0 Hz, J32,33 = 3.0 Hz, 33-HZ), 4.74 (0.8H, dd, J31,32 = 7.3 Hz,
J32,33 = 2.8 Hz, 32-HE), 2.71–2.65 (0.2H, m, 22-HZ), 2.17–2.11
(0.8H, m, 22-HE), 1.65 and 1.41 (6H, 2s, Me2C), 1.01 (0.6H, d,
J22,29 = 6.2 Hz, 22R-MeZ), 0.97 and 0.95 (1.2H, 2s, 8β-MeZ and
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14α-MeZ), 0.93 and 0.92 (4.8H, 2s, 8β-MeE and 14α-MeE), 0.89
(2.4H, d, J22,29 = 6.4 Hz, 22R-MeE), 0.84 (18H, s, 4α-Me), 0.80
(3H, s, 10β-Me), 0.781 (3H, s, 4β-Me), 0.64 (3H, s, 18α-Me).
13C-NMR of the major isomer (E)-11 (75 MHz, C2HCl3):
δ/ppm = 164.5, 152.6, 151.1, 149.6, 142.1, 133.6, 132.7, 128.7,
127.8, 124.5, 123.5, 114.3, 91.2, 88.6, 84.8, 84.4, 56.0, 54.0,
50.3, 49.1, 44.8, 44.3, 42.0, 41.8, 41.7, 41.5, 40.5, 40.2, 37.3,
33.4, 33.3, 33.2, 33.2, 27.5, 27.0, 25.4, 23.9, 21.9, 21.7, 21.5,
20.9, 18.6, 16.5, 15.9, 15.8.
HRMS (ESI): m/z [M + Na]+, calcd for C50H69N5NaO4
+
826.524, found 826.524.
Homodimer of 5′-methylene adenosine (15)
Dimer 15 was isolated as a solid mixture of two E/Z isomers
(∼3 : 1). Rf = 0.16 (CH2Cl2–MeOH, 100 : 3).
1H-NMR (300 MHz, C2HCl3) (subscripts “E” and “Z” charac-
terize respectively the 1H-NMR signals of (E)-15 and (Z)-15,
which are respectively present in a 3 : 1 ratio): δ/ppm = 9.24
(1.5H, br. s, –NHBzE), 9.11 (0.5H, br. s, –NHBzZ), 8.79 (0.5H,
br. s, 2-HZ), 8.63 (1.5H, br. s, 2-HE), 8.10 (0.5H, s, 8-HZ),
8.04–8.02 (4H, m, Ar-H), 7.95 (1.5H, s, 8-HE), 7.64–7.44 (6H, m,
Ar-H), 6.15 (0.5H, d, J1′,2′ = 1.5 Hz, 1′-HZ), 6.06 (1.5H, d, J1′,2′ =
1.7 Hz, 1′-HE), 5.72 (1.5H, dd, J = 3.4, 1.5 Hz, 5′-HE), 5.63 (0.5H,
dd, J = 5.5, 1.3 Hz, 5′-HZ), 5.56 (0.5H, dd, J2′,3′ = 6.1 Hz, J1′,2′ =
1.5 Hz, 2′-HZ), 5.44 (1.5H, dd, J2′,3′ = 6.3 Hz, J1′,2′ = 1.7 Hz,
2′-HE), 5.14–5.11 (0.5H, m, 3′-HZ), 4.94 (1.5H, dd, J2′,3′ = 6.3,
J3′,4′ = 3.3 Hz, 3′-HE), 4.69–4.67 (0.5H, m, 4′-HZ), 4.63 (1.5H, m,
4′-HE), 1.63 and 1.38 (3H, 2s, Me2CZ), 1.59 and 1.36 (9H,
2s, Me2CE).
13C-NMR (75 MHz, C2HCl3): δ/ppm = 164.7E, 152.7Z, 152.4E,
150.9E, 149.8Z, 149.7E, 142.4Z, 142.3E, 133.5E, 133.4Z, 132.8Z,
132.7E, 131.2Z, 130.0E, 128.9Z, 128.7E, 128.0E, 127.9Z, 123.6E,
114.6Z, 114.5E, 91.1Z, 90.7E, 87.3E, 85.4Z, 84.5E, 84.3Z, 84.0E,
83.5Z, 27.0E, 27.0Z, 25.3Z, 25.2E.
HRMS (ESI): m/z [M + Na]+, calcd for C40H38N10NaO8
+
809.277, found 809.277.
(E)-33,34-O-Isopropylidene adenosylhop-30-ene ((E)-12) and
(Z)-33,34-O-isopropylidene adenosylhop-30-ene ((Z)-12)
To a mixture of compounds (E)-11 and (Z)-11 (150 mg,
0.19 mmol) in CH2Cl2 (5 mL) was added a solution of
ammonia in MeOH (7N, 20 mL) at 0 °C, and the mixture was
stirred at 5 °C for 5 days. The volatiles were evaporated and the
residue was purified via flash chromatography (CH2Cl2 to
CH2Cl2–MeOH, 100 : 2) to give a mixture of (E)-12 and (Z)-12
(120 mg, 0.17 mmol, 91%) as a colourless solid, which was
used in the next step without further purification. Rf = 0.36
(CH2Cl2–MeOH, 100 : 5).
1H-NMR (300 MHz, C2HCl3) for (E)-12 and (Z)-12 (subscripts
“E” and “Z” characterize respectively the 1H-NMR signals of
(E)-12 and (Z)-12, which are respectively present in a 4 : 1
ratio): δ/ppm = 8.36 (0.2H, s, 2′-HZ), 8.35 (0.8H, s, 2′-HE), 7.91
(0.2H, s, 8′-HZ), 7.89 (0.8H, s, 8′-HE), 6.07 (1H, d, J34,35 = 1.8 Hz,
35-HZ and 35-HE), 5.90 (2H, br. s, –NH2), 5.54 (0.8H, dd,
J33,34 = 6.2 Hz, J34,35 = 1.9 Hz, 34-HE), 5.50 (0.2H, dd, J33,34 =
6.2 Hz, J34,35 = 1.9 Hz, 34-HZ), 5.45 (0.8H, dd, J30,31 = 15.3 Hz,
J22,30 = 8.1 Hz, 30-HE), 5.36 (0.8H, dd, J30,31 = 15.3 Hz, J31,32 =
6.8 Hz, 31-HE), 5.31–5.29 (0.4H, m, 31-HZ and 30-HZ), 4.97
(0.2H, dd, J31,32 = 4.7 Hz, J32,33 = 2.9 Hz, 32-HZ), 4.94 (0.8H, dd,
J33,34 = 6.3 Hz, J32,33 = 3.1 Hz, 33-HE), 4.83 (0.2H, dd, J33,34 = 6.3
Hz, J32,33 = 3.1 Hz, 33-HZ), 4.69 (0.8H, dd, J31,32 = 6.8 Hz,
J32,33 = 2.9 Hz, 32-HE), 2.72–2.63 (0.2H, m, 22-HZ), 2.17–2.09
(0.8H, m, 22-HE), 1.63 (0.6H, s, Me2CZ), 1.61(2.4H, s, Me2CE),
1.40 (3H, s, Me2C), 1.00 (0.6H, d, J22,29 = 6.4 Hz, 22R-MeZ), 0.96
and 0.94 (1.2H, 2s, 8β-MeZ and 14α-MeZ), 0.93 (2.4H, s,
8β-MeE), 0.92 (2.4H, s, 14α-MeE), 0.89 (2.4H, d, J22,29 = 6.4 Hz,
22R-MeE), 0.834 (3H, s, 4α-Me), 0.799 (3H, s, 10β-Me), 0.779
(3H, s, 4β-Me), 0.640 (3H, s, 18α-Me).
13C-NMR (75 MHz, C2HCl3) for (E)-12: δ/ppm = 155.5, 153.0,
149.4, 141.7, 139.8, 124.8, 120.3, 114.2, 90.8, 88.4, 85.0, 84.4,
56.1, 54.1, 50.4, 49.1, 44.9, 44.3, 42.1, 41.8, 41.7, 41.6, 40.5,
40.3, 37.4, 33.5, 33.4, 33.3, 33.2, 27.5, 27.1, 25.4, 23.9, 22.1,
22.0, 21.7, 21.6, 20.9, 18.7, 16.6, 15.9.
HRMS (ESI): m/z [M + H]+, calcd for C43H65N5NaO3
+
722.498, found 722.497.
33,34-O-Isopropylidene adenosylhopane (13)
To a stirred slurry of potassium azodicarboxylate (90 mg,
0.46 mmol) in pyridine (1 mL) in a two-neck round bottom
flask equipped with a condenser under N2 atmosphere was
added a solution of 12 (32 mg, 0.046 mmol) in pyridine
(3 mL). The mixture was heated to reflux, and a solution of
anhydrous acetic acid (0.030 mL, 0.55 mmol) in pyridine
(0.1 mL) was carefully added dropwise. Each drop of acetic
acid solution was added after the end of N2 evolution. The
mixture was left under reflux until the yellow colour vanished.
Another five portions of potassium azodicarboxylate and sub-
sequent acetic acid were necessary to increase the conversion.
The reaction was quenched with water, and extracted with
dichloromethane three times. The combined organic phases
were washed with brine and dried over anhydrous Na2SO4, fil-
tered through cotton, and evaporated to dryness in vacuo. The
crude product was further purified by flash chromatography
(CH2Cl2–MeOH 100 : 1 to 100 : 2) to yield the saturated product
13 (23 mg, 73%). Compound 13 was isolated as a colourless
solid. Rf = 0.38 (CH2Cl2–MeOH, 100 : 5).
M.p. = 256–257 °C. [α]20D = +34 (c 0.35, CHCl3).
1H-NMR (C2HCl3, 300 MHz): δ/ppm = 8.35 (1H, s, 2′-H),
7.89 (1H, s, 8′-H), 6.03 (1H, dd, J34,35 = 2.4 Hz, 35-H), 5.85 (2H,
s, –NH2), 5.51 (1H, J33,34 = 6.5 Hz, J34,35 = 2.4 Hz, 34-H), 4.80
(1H, dd, J33,34 = 6.5 Hz, J32,33 = 3.5 Hz, 33-H), 4.15 (1H, ddd,
J31a,32 = 7.4 Hz, J31b,32 = 6.5 Hz, J32,33 = 3.5 Hz, 32-H), 1.60 and
1.38 (2 × 3H, 2s, Me2C), 0.928 (3H, s, 8β-Me), 0.921 (3H, S,
14α-Me), 0.83 (3H, d, J = 6.2 Hz, 22-Me), 0.834 (3H, s, 4α-Me),
0.800 (3H, s, 10β-Me), 0.779 (3H, s, 4β-Me), 0.656 (3H, s,
18α-Me).
13C-NMR data (C2HCl3, 75 MHz): δ/ppm = 155.4 (C-6′),
153.0 (C-2′), 139.8 (C-8′), 149.4 (C-4′), 120.3 (C-5′), 114.4
(CMe2), 90.5 (C-35), 87.7 (C-32), 84.3 (C-34), 84.0 (C-33), 56.1
(C-5), 54.4 (C-17), 50.4 (C-9), 49.3 (C-13), 45.7 (C-21), 44.3
(C-18), 42.1 (C-3), 41.8 (C-14), 41.7 (C-8), 41.5 (C-19), 40.3 (C-1),
37.4 (C-10), 36.4 (C-22), 33.6 (C-15), 33.4 (C-23), 33.2 and 33.1
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(C-4 and C-7), 31.4 (C-30), 30.0 (C-31), 27.5 (C-20), 23.9 (C-12),
22.7 (C-16), 21.6 (C-24), 20.9 (C-11), 20.0 (C-29), 18.7 (C-2 and
C-6), 16.6 and 16.5 (C-26 and C-27), 15.9 and 15.8 (C-25 and
C-28).
HRMS (ESI): m/z [M + H]+, calcd for C43H67N5NaO3
+
724.514, found 724.512.
[30,31-2H2]-33,34-O-Isopropylidene adenosylhopane (13-D)
Compound 12 (51 mg, 0.073 mmol) was dissolved in a mixture
of CH3O
2H–C2HCl3 (1 : 2) under an atmosphere of N2 for H-
2H
exchange. After 5 min standing, the solvents were carefully
evaporated under vacuum. The same procedure was repeated
three times, and the N-deuteriated intermediate 12-D was care-
fully dried overnight under vacuum in the presence of P2O5.
Compound 13-D was prepared following the procedure
described for the synthesis of natural abundance 13 using pot-
assium azodicarboxylate (850 mg, 43.8 mmol) and CH3COO
2H
(98% isotope abundance, 3.3 mL, 56.9 mmol) to generate deu-
teriated diimide in situ. Compound 13-D (31 mg, 60%) was iso-
lated as a colourless solid with unreacted starting material 12
(8.6 mg, 17%) by TLC (CH2Cl2–MeOH, 100 : 5, Rf = 0.38). Deu-
terium content of 13-D was determined from HRMS (ESI) spec-
trum by evaluating the relative intensities of the m/z 724, 725
and 726 peaks corresponding to each isotopomer: natural
abundance adenosylhopane (8%), monodeuteriated adenosyl-
hopane (32%) and bisdeuteriated adenosylhopane (60%), tris-
deuteriated adenosylhopane (0%).
1H-NMR (C2HCl3, 600 MHz): δ/ppm = 8.35 (1H, s, 2′-H),
7.90 (1H, s, 8′-H), 6.03 (1H, d, J34,35 = 2.4 Hz, 35-H), 5.92 (2H, s,
–NH2), 5.51 (1H, ddd, J33,34 = 6.4 Hz, J34,35 = 2.4 Hz, J32,34 =
1.2 Hz, 34-H), 4.80 (1H, ddd, J33,34 = 6.4 Hz, J32,33 = 3.5 Hz,
J31,33 = 1.2 Hz, 33-H), 4.15 (1H, dd for the major isotopomer,
J31,32 = 7.2 Hz, J32,33 = 3.5 Hz, 32-H), 1.60 and 1.38 (2 × 3H, 2s,
Me2C), 0.927 (3H, s, 8β-Me), 0.920 (3H, S, 14α-Me), 0.833 (3H,
s, 4α-Me), 0.832 (3H, d, J = 6.3 Hz, 22-CH3), 0.798 (3H, s,
10β-Me), 0.778 (3H, s, 4β-Me), 0.655 (3H, s, 18α-Me).
13C-NMR data (C2HCl3, 150 MHz): δ/ppm = 155.5 (C-6′),
152.9 (C-2′), 139.8 (C-8′), 149.4 (C-4′), 120.3 (C-5′), 114.4
(CMe2), 90.5 (C-35), 87.63 and 87.60 (C-32, β-shift induced by
deuterium at C-31), 84.3 (C-34), 84.0 (C-33), 56.1 (C-5), 54.3
(C-17), 50.4 (C-9), 49.2 (C-13), 45.7 (C-21), 44.3 (C-18), 42.1
(C-3), 41.8 (C-14), 41.6 (C-8), 41.5 (C-19), 40.3 (C-1), 37.4 (C-10),
36.35, 36.28 and 36.25 (C-22, β-shifts induced by deuterium
at C-30), 33.6 (C-15), 33.4 (C-23), 33.2 and 33.1 (C-4 and
C-7), missing signal (C-30 bearing a deuterium), missing
signal (C-31 bearing a deuterium), 27.5 (C-20), 23.9 (C-12),
22.7 (C-16), 21.6 (C-24), 20.9 (C-11), 20.0 (C-29), 18.7 (C-2
and C-6), 16.6 and 16.5 (C-26 and C-27), 15.9 and 15.8 (C-25
and C-28).
HRMS (ESI): m/z [M + H]+, calcd for C43H65D2N5NaO3
+
726.526, found 726.523.
Adenosylhopane (2)
A solution of 13 (6.3 mg, 9 µmol) and TFA (2 mL) in CHCl3–
MeOH (2 : 1, 5 mL) in a round bottomed flask was shaken
under reduced pressure (450–500 mbar) at 0 °C for 2 h30
(rotary evaporator). When starting material could no more be
detected by TLC, the reaction mixture was evaporated to
dryness and the residue was purified by column chromato-
graphy over silica gel (63–200 µm) (CHCl3–MeOH–NH4OH,
100 : 2 : 0.5 to 100 : 5 : 0.5 to 100 : 7.5 : 0.5) to aﬀord adenosyl-
hopane 2 as a colourless solid (5.3 mg, 8 µmol 90%). Rf = 0.09
(CH2Cl2–MeOH 100 : 5). [α]
20
D = +34 (c 0.3, THF).
1H-NMR ((2H5)pyridine, 600 MHz): δ (ppm) = 8.77 (1H, s,
2′-H), 8.61 (1H, s, 8′-H), 8.29 (2H, s, –NH2), 7.74 (1H, d, J34,OH =
5.5 Hz, 34-OH), 7.04 (1H, d, J33,OH = 5.8 Hz, 33-OH), 6.72 (1H,
d, J34,35 = 4.4 Hz, 35-H), 5.43 (1H, pseudo q, J = 4.7 Hz, 34-H),
4.77 (1H, pseudo q, J = 5.2 Hz, 33-H), 4.56 (1H, pseudo dt, J =
8.4 Hz, J = 4.9 Hz, 32-H), 2.13 (1H, m, 31-Ha), 1.96 (1H, m,
31-Hb), 1.79 (2H, m, 30-Ha and 20-Ha), 1.73 (1H, m, 21-H),
0.994 (3H, d, J = 6.3 Hz), 0.959 (3H, s, 8β-Me), 0.948 (3H, s,
14α-Me), 0.882 (3H, s, 4α-Me), 0.819 (3H, s, 4β-Me), 0.815 (3H,
s, 10β-Me), 0.665 (3H, s, 18α-Me).
13C-NMR ((2H5)pyridine, 150 MHz): δ (ppm) = 157.6 (C-6′),
153.8 (C-2′), 150.6 (C-4′), 140.0 (C-8′), 121.3 (C-5′), 90.0 (C-35),
85.2 (C-32), 75.24 and 75.16 (C-33 and C-34), 54.6 (C-17), 56.4
(C-5), 50.7 (C-9), 49.6 (C-13), 46.4 (C-21), 44.5 (C-18), 42.3(C-3),
42.0 (C-14), 41.9 (C-8), 41.8 (C-19), 40.5 (C-1), 37.6 (C-10), 36.9
(C-22), 34.0 (C-15), 33.6 (C-7 and C-23), 33.4 (C-4), 32.3 (C-30),
31.0 (C-31), 27.9 (C-20), 24.2 (C-12), 23.0 (C-16), 21.8 (C-24),
21.2 (C-11), 20.4 (C-29), 19.0 (C-2 and C-6), 16.8 and 16.7 (C-26
and C-27), 16.1 and 16.0 (C-25 and C-28).
HRMS (ESI): m/z [M + H]+, calcd for C40H64N5O3
+ 662.501,
found 662.500.
(30,31-2H2)Adenosylhopane (2-D)
Deprotection of 13-D (9.3 mg, 13.2 µmol) by TFA (3 mL) in
CHCl3–MeOH (2 : 1, 7 mL) following procedure D aﬀorded deu-
teriated adenosylhopane 2-D (7.7 mg, 11.6 µmol, 90%). Rf =
0.09 (DCM–MeOH 100 : 5). Deuterium content of 2-D was cal-
culated from HRMS (ES) spectrum: natural abundance adeno-
sylhopane 8%; monodeuteriated adenosylhopane 32%;
bisdeuteriated adenosylhopane 60%; trisdeuteriated adenosyl-
hopane 0%.
1H-NMR ((2H5)pyridine, 600 MHz): δ (ppm) = 8.72 (1H, s,
2′-H), 8.60 (1H, s, 8′-H), 8.28 (2H, s, –NH2), 7.73 (1H, d, J34,OH =
5.1 Hz, 34-OH), 7.03 (1H, d, J33,OH = 5.6 Hz, 33-OH), 6.72 (1H,
d, J34,35 = 4.4 Hz, 35-H), 5.43 (1H, pseudo q, J = 4.3 Hz, 34-H),
4.77 (1H, pseudo q, J = 5.0 Hz, 33-H), 4.57–4.54 (1H, m, 32-H),
2.11 (1H, dd, J31a, 32 = 8.3 Hz, J30b,31a = 4.6 Hz, 31-Ha), 1.93
(1H, pseudo t, J31b,32 = J30a,31b = 5.0 Hz, 31-Hb), 1.82–1.71
(2.7H, m, 30-Ha, 20-Ha and 21-H of isotopomer resulting from
deuteriation of major isomer E-12), 1.75–1.72 (1H, m, 21-H),
0.993 (3H, d, J = 6.3 Hz), 0.961 (3H, s, 8β-Me), 0.949 (3H, s,
14α-Me), 0.883 (3H, s, 4α-Me), 0.820 (3H, s, 4β-Me), 0.816 (3H,
s, 10β-Me), 0.667 (3H, s, 18α-Me).
13C-NMR ((2H5)pyridine, 150 MHz): δ (ppm) = 157.6 (C-6′),
153.8 (C-2′), 150.6 (C-4′), 140.0 (C-8′), 121.3 (C-5′), 90.0 (C-35),
85.20 and 85.15 (C-32, β-shift induced by deuterium at C-31),
75.21 and 75.15 (C-33 and C-34), 54.6 (C-17), 56.4 (C-5), 50.7
(C-9), 49.6 (C-13), 46.4 (C-21), 44.5 (C-18), 42.3(C-3), 42.0
(C-14), 41.9 (C-8), 41.8 (C-19), 40.5 (C-1), 37.6 (C-10), 36.90,
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36.86 and 36.81 (C-22, β-shifts induced by deuterium at C-30),
33.9 (C-15), 33.6 (C-7 and C-23), 33.4 (C-4), missing signal at
ca. 32.3 (C-30 bearing a deuterium), missing signal at ca. 31.0
(C-31 bearing a deuterium), 27.9 (C-20), 24.2 (C-12), 23.0
(C-16), 21.8 (C-24), 21.2 (C-11), 20.3 (C-29), 19.0 (C-2 and C-6),
16.8 and 16.7 (C-26 and C-27), 16.1 and 16.0 (C-25 and C-28).
HRMS (ESI): m/z [M + H]+, calcd for C40H62
2H2N5O3
+
664.513, found 664.513.
Adenosylhopane acetates (14a–c)
Adenosylhopane 2 (1.8 mg) was acetylated overnight at room
temperature with a mixture of acetic anhydride and pyridine
(0.3 mL, v/v, 1/2). Reagents were removed under vacuum. The
resulting residue was purified by preparative thin layer chromato-
graphy (CH2Cl2–MeOH, 100 : 5) to aﬀord adenosylhopane
diacetate 14a (0.4 mg, Rf = 0.30), triacetate 14b (0.6 mg, Rf =
0.38)1a,b and tetraacetate 14c (0.8 mg, Rf = 0.66).
Adenosylhopane diacetate (14a). 1H-NMR (300 MHz,
C2HCl3): δ/ppm = 8.30 and 7.95 (2 × 1H, 2s, 2′-H and 8′-H),
6.68 (2H, br. s, –NH2), 6.14 (1H, d, J = 5.5 Hz, 35-H), 5.87 (1H,
dd, J = 5.7, 5.5 Hz, 34-H), 5.38 (1H, dd, J = 5.5, 4.5 Hz, 33-H),
4.15 (1H, td, J = 8.4, 4.3 Hz, 32-H), 2.14 (3H, s, CH3COO–), 2.06
(3H, s, CH3COO–), 0.94 (9H, m, 8β-Me, 14α-Me and 22R-Me),
0.84 (3H, s, 4α-Me), 0.81 (3H, s, 10β-Me), 0.79 (3H, s, 4β-Me),
0.68 (3H, s, 18α-Me).
MS (EI, direct inlet, positive mode 70 eV): m/z = 746 (M+,
9%), 686 (M+ − AcOH, 6%), 626 (M+ − 2AcOH, 24%), 595 (6%),
538 (15%), 491 (5%), 389 (17%), 367 (M+ − CH2CO − side
chain, 9%), 191 (ring C cleavage, 10%), 136 ([adenine + H]+,
100%).
Adenosylhopane triaacetate (14b). 1H-NMR (300 MHz,
C2HCl3): δ/ppm = 8.87 (1H, s, NHCOCH3), 8.69 and 8.06
(2 × 1H, 2s, 2′-H and 8′-H), 6.14 (2H, d, J = 5.5 Hz, 35-H), 5.94
(1H, dd, J = J = 5.5 Hz, 34-H), 5.42 (1H, dd, J = 5.5, 4.5 Hz,
33-H), 4.17 (1H, td, J = 8.4, 4.3 Hz, 32-H), 2.60 (3H, s,
CH3CONH–), 2.15 (3H, s, CH3COO–), 2.06 (3H, s, CH3COO–),
0.94 (9H, m, 8β-Me, 14α-Me and 22R-Me), 0.84 (3H, s, 4α-Me),
0.81 (3H, s, 10β-Me), 0.79 (3H, s, 4β-Me), 0.68 (3H, s, 18α-Me).
MS (EI, direct inlet, positive mode 70 eV): m/z = 788 (M+,
2%), 610 (M+ − N,N-acetyladenine, 4%), 595 (ring C cleavage,
2%), 491 (1%), 389 (6%), 367 (M+ − CH2CO − side chain, 4%),
191 (ring C cleavage, 11%), 178 ([N-acetyladenine + H]+, 100%).
Adenosylhopane tetraacetate (14c). 1H-NMR (300 MHz,
C2HCl3): δ/ppm = 8.97 and 8.21 (2 × 1H, 2s, 2′-H and 8′-H),
6.18 (2H, d, J = 5.5 Hz, 35-H), 5.96 (1H, dd, J = J = 5.5 Hz, 34-
H), 5.42 (1H, dd, J = 5.5, 4.5 Hz, 33-H), 4.21–4.17 (1H, m, 32-
H), 2.37 (6H, s, 2 × CH3CONH–), 2.16 (3H, s, CH3COO–), 2.09
(3H, s, CH3COO–), 0.94 (6H, br. s, 8β-Me and 14α-Me), 0.94
(3H, d, J = 6.1 Hz, 22R-Me), 0.84 (3H, s, 4α-Me), 0.81 (3H, s,
10β-Me), 0.79 (3H, s, 4β-Me), 0.69 (3H, s, 18α-Me).
MS (EI, direct inlet, positive mode 70 eV): m/z = 830 (M+,
0.3%), 788 (M+ − CH2CO), 662 (1%), 610 (M+ − CH2CO − N,N-
diacetyladenine, 8%), 595 (ring C cleavage − CH2CO, 5%), 491
(3%), 389 (16%), 367 (M+ − CH2CO − side chain, 8%), 191
(ring C cleavage, 20%), 178 (100%).
Culture of M. organophilum and preparation of the cell-free
system
Methylobacterium organophilum DSM 760 was grown on a
modified medium of Hestrin and Schramm36 (6 × 500 mL,
yeast extract 5 g L−1, bactopeptone 5 g L−1, glucose 1 g L−1,
anhydrous citric acid 1.04 g L−1, Na2HPO4 2.7 g L
−1, pH = 6.8)
in 2 L Erlenmeyer flasks on a rotatory shaker (200 rpm) at
30 °C. Optical densities of the bacterial cultures were
measured at 595 nm on a Genesys 10UV spectrophotometer
using 1 cm in length and 1 mL volume cuvettes. The cells were
harvested before the end of the exponential growth phase (OD
∼ 0.6) by centrifugation (8 000 rpm, 10 min), and then washed
with buﬀer either a sodium phosphate buﬀer (50 mM
NaH2PO4–Na2HPO4, 0.5 mM, MgCl2, 1 mM dithiothreitol, pH
7.5) or a triethylamine buﬀer (0.1 M triethylamine, 0.5 mM
MgCl2, 1 mM dithiothreitol, pH 7.5). After centrifugation (8
000 rpm, 10 min), the cell pellet (3 g) was suspended in the
buﬀer (15 mL) and disrupted by sonication at 0 °C in a
melting ice bath using a Branson SONIFIER B-30 (8 × 40 s with
3 min pause at 0 °C, 60% pulsed duty cycle, output control: 6).
The crude cell-free system was centrifuged (10 000 rpm,
10 min). The pellet was freeze-dried to recover bacteriohopane-
tetrol of natural abundance, and the supernatant was directly
used for the incubation deuterium labelled adenosylhopane.
Conversion of deuteriated adenosylhopane into
bacteriohopanetetrol by a crude cell-free system from
M. organophilum
A solution of deuteriated adenosylhopane 2-D (200 μg) in THF
(500 µL) was added to the supernatant (5 mL) described above
in a glass screw cap vial. After addition of a solution of NADPH
(1.5 mg) in water (100 µL), the sample was incubated at 30 °C
by shaking (200 rpm). An additional portion of the cofactor
solution (100 µL) was added after 4 h incubation and the
sample was incubated for another 20 h. After lyophilisation,
the residue was directly acetylated overnight at room tempera-
ture with Ac2O–pyridine (1 : 2 v/v, 3.9 mL). The reaction
mixture was filtered over cotton and washed with toluene (3 ×
2 mL) and CH2Cl2 (3 × 2 mL). The combined filtrates were con-
centrated in vacuo, and the residue was subjected to prepara-
tive TLC (cyclohexane–ethyl acetate, 3 : 7) to give an apolar
fraction (Rf > 0.7) containing diploptene, diplopterol and
acetylated bacteriohopanetetrol. This less polar fraction was
further separated by TLC (cyclohexane–ethyl acetate, 5 : 1),
yielding pure bacteriohopanetetrol tetraacetate (0.16 < Rf <
0.20), which was analysed by GC-EIMS.
Isolation of natural abundance bacteriohopanetetrol from
M. organophilum or from cell-free system unbroken cells and
cell debris pellet
The freeze-dried material (unbroken cells and large cell debris)
recovered after the centrifugation yielding the supernatant
used for the incubations was extracted with CHCl3–CH3OH
(2 : 1, v/v) three times under reflux. The combined extracts
were brought to dryness, acetylated with Ac2O–pyridine (1 : 2,
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v/v) and the excess of reagents was evaporated in vacuo. The
residue was separated by preparative TLC (silica gel, cyclo-
hexane–ethyl acetate, 3 : 7) to give an apolar fraction (Rf > 0.7)
containing diploptene, diplopterol, and acetylated bacterioho-
panetetrol. This mixture was further separated by preparative
TLC (silica gel, cyclohexane–ethyl acetate, 5 : 1), yielding pure
bacteriohopanetetrol tetraacetate (0.16 < Rf < 0.20).
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